Drug & Alcohol Rehab Centers in Maryland
Maryland has approximately 600 licensed addiction treatment facilities, serving a state where the overdose crisis has been among the deadliest in the nation on a per capita basis. The Behavioral Health Administration (BHA), a division of the Maryland Department of Health (MDH), oversees the licensing, regulation, and funding of substance use disorder treatment across the state's 23 counties and Baltimore City. Maryland's treatment system benefits from two of the world's foremost academic medical centers — Johns Hopkins University in Baltimore and the University of Maryland Medical System — which have pioneered addiction medicine research and clinical practice for decades.
In 2022, Maryland recorded approximately 2,900 drug overdose deaths — giving it one of the highest per capita overdose death rates in the United States. The opioid crisis has been centered in Baltimore, which alone accounts for a disproportionate share of the state's fatalities, driven by entrenched heroin markets that transitioned to illicitly manufactured fentanyl. Alcohol use disorder remains the most prevalent substance use condition statewide, while cocaine is frequently involved in overdose deaths, often in combination with fentanyl. Methamphetamine use, though historically low in Maryland, has increased in recent years, particularly on the Eastern Shore and in Western Maryland.
Maryland's treatment infrastructure spans the full ASAM continuum of care. From medical detoxification and residential treatment to intensive outpatient (IOP) programs and telehealth services, the state offers comprehensive recovery pathways. Maryland has been a national leader in expanding access to medication-assisted treatment (MAT), with the landmark Heroin and Opioid Prevention Effort (HOPE) Act of 2017 requiring hospitals to screen for substance use disorders and connect patients to treatment. Evidence-based approaches including cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and contingency management are widely integrated into Maryland's licensed programs.
Addiction Treatment Landscape in Maryland
Maryland's addiction treatment system is coordinated by the Behavioral Health Administration (BHA) within the Maryland Department of Health (MDH). BHA licenses providers, administers state and federal funding, operates the statewide crisis system, and manages Maryland's 211 Press 1 crisis hotline. The agency works with local addiction authorities (LAAs) in each jurisdiction to ensure treatment access across the state's diverse geography — from the densely urban Baltimore corridor to the rural Eastern Shore and Western Maryland mountains.
Key statistics:
- Approximately 2,900 drug overdose deaths in 2022 (Maryland Department of Health)
- About 600 licensed treatment facilities statewide (SAMHSA N-SSATS)
- Fentanyl involved in over 90% of opioid-related overdose deaths
- Baltimore City's overdose death rate is among the highest of any major U.S. city
The Baltimore opioid crisis has defined Maryland's treatment landscape for decades. Baltimore's heroin epidemic dates to the 1960s, and the city's entrenched open-air drug markets facilitated a rapid transition to fentanyl beginning around 2015. Baltimore City alone accounts for roughly one-third of Maryland's overdose deaths, despite having less than 10% of the state's population. The HOPE Act (Heroin and Opioid Prevention Effort), signed into law in 2017, was landmark legislation that required hospital emergency departments to screen patients for substance use disorders, established crisis treatment centers, expanded naloxone access, and increased funding for treatment and recovery services statewide.
Regional treatment patterns vary across Maryland. Baltimore and the central corridor have the highest density of treatment providers, including Johns Hopkins' world-renowned addiction research and clinical programs and the University of Maryland Medical System's behavioral health network. The Washington, D.C., suburbs of Montgomery and Prince George's counties have growing treatment infrastructure serving diverse communities. The Eastern Shore faces elevated opioid and methamphetamine use with fewer treatment options and greater reliance on telehealth. Western Maryland (Allegany, Garrett, Washington counties) contends with Appalachian-pattern opioid use. Maryland's treatment system increasingly emphasizes co-occurring mental health disorders, harm reduction, and low-barrier access to MAT.
Types of Treatment Available in Maryland
Maryland offers the full ASAM continuum of addiction care through its licensed treatment network:
- Medical Detoxification: Hospital-based and standalone withdrawal management programs in Baltimore, the D.C. suburbs, Annapolis, Frederick, and other regions. Johns Hopkins Hospital and the University of Maryland Medical Center operate medically managed detox for complex cases. Maryland's HOPE Act crisis treatment centers also provide stabilization and detox services.
- Residential Treatment: Programs from 30 to 90+ days across the state, including clinical programs in the Baltimore metro, retreat-style facilities in rural Maryland, and long-term therapeutic communities. Maryland licenses both short-term and long-term residential providers under BHA regulations.
- Partial Hospitalization (PHP): Structured day programs available in Baltimore, the D.C. suburbs, and other metro areas, offering 5-7 days per week of intensive clinical treatment.
- Intensive Outpatient (IOP): Flexible 3-5 day per week programs widely available across Maryland. IOP is among the most commonly utilized levels of care in the state, allowing clients to maintain work and family responsibilities during recovery.
- Standard Outpatient: Weekly individual and group therapy through community behavioral health centers, private practices, and federally qualified health centers statewide.
- Telehealth Services: Maryland permanently expanded telehealth coverage for addiction treatment. Telehealth is essential for serving the Eastern Shore and Western Maryland, where in-person treatment options are limited.
Maryland is nationally recognized for its leadership in medication-assisted treatment and harm reduction. Johns Hopkins and the University of Maryland have conducted groundbreaking research on buprenorphine, methadone, and other pharmacotherapies for opioid use disorder. Baltimore's needle exchange program, established in 1994, was one of the first in the nation. 12-step programs, SMART Recovery, and other mutual aid groups are widely available. Many facilities integrate CBT, trauma-informed care, and MAT into comprehensive treatment plans.
Insurance & Maryland Medicaid Coverage
Maryland Medicaid expanded under the Affordable Care Act, extending coverage to adults earning up to 138% of the federal poverty level. This expansion significantly increased access to addiction treatment for low-income Marylanders. Maryland Medicaid covers comprehensive substance use disorder treatment services including:
- Screening, assessment, and diagnosis
- Inpatient detoxification and residential treatment
- Partial hospitalization programs
- Outpatient and intensive outpatient treatment
- Medication-assisted treatment (methadone, buprenorphine, naltrexone)
- Peer recovery support services
- Case management and care coordination
- Crisis intervention and stabilization
Maryland Medicaid is administered through HealthChoice, the state's managed care program, with participating managed care organizations including Amerigroup, CareFirst Community Health Plan, Johns Hopkins HealthCare, Jai Medical Systems, Maryland Physicians Care, MedStar Family Choice, Molina Healthcare, Priority Partners, and UnitedHealthcare. Maryland has been proactive in requiring managed care organizations to ensure timely access to MAT and substance use disorder treatment.
Private insurance plans in Maryland must comply with both the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and Maryland's own behavioral health parity laws, requiring coverage of addiction treatment at parity with medical and surgical benefits. Major insurers including CareFirst BlueCross BlueShield, Aetna, Cigna, and UnitedHealthcare cover the full continuum of addiction care.
For uninsured individuals, Maryland's local addiction authorities (LAAs) in each jurisdiction provide publicly funded treatment through state and federal grants. BHA distributes opioid settlement funds and State Opioid Response (SOR) grants to community providers. Contact Maryland's 211 Press 1 hotline or SAMHSA's National Helpline at 1-800-662-4357 for referrals to free and low-cost treatment.
Want us to find the perfect facility for you?
Call now - it's completely free!
Showing 20 of 418 results

Eastern Shore






Baltimore County

Villa Maria Behavioral Health/Fallst



Harford County




Washington

Villa Maria Behav Health of Harford

Cumberland Comprehensive Treatment Cen

Pine Heights Treatment Center


Treatment Highlights in Maryland
Popular Cities in Maryland
Frequently Asked Questions About Treatment in Maryland
Sources
Medical Disclaimer
The information on this page is for educational purposes and is not a substitute for professional medical advice. If you or someone you know is experiencing a substance use crisis, call the SAMHSA National Helpline at 1-800-662-4357 (free, confidential, 24/7). For immediate danger, call 911 or the 988 Suicide & Crisis Lifeline by dialing 988.